Author

Hong Qin

Mayo Clinic in FloridaORCID 0000-0001-7463-2914Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hong Qin1 paper · Regenerative Immunotherapy & CAR-T Translational Research Program, Department of Cancer Biology, Division of Hematology and Medical Oncology, Department of Internal Medicine, Department of Immunology, Mayo Clinic, MN, USA

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aleeshba N. BasiliD· 1 shared Alfredo Quiñones‐HinojosaiD· 1 shared Andrew David BrimiD· 1 shared Cristina Gomez-PalmeroiD· 1 shared Frederick Q Tutor‐New· 1 shared Haidong DongiD· 1 shared Jacob B. HirdleriD· 1 shared Jesus Emiliano Sanchez-GaravitoiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleeshba N. BasilORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 22, 2024

Single CAR-Dual target: Intracranial Delivery of Anti-PD-L1 CAR T Cells Effectively Eradicates Glioma and Immunosuppressive Cells in the Tumor Microenvironment.

María José Ulloa-Navas, Yan Luo, Jesus Emiliano Sanchez-Garavito…·Alfredo Quiñones‐Hinojosa

This study develops a PD-L1-targeting CAR T cell therapy, MC9999, which effectively eradicates glioblastoma and immunosuppressive cells in the tumor microenvironment through intracranial delivery.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky